H.PIO Co., Ltd. (KOSDAQ:357230)
2,135.00
+55.00 (2.64%)
At close: Aug 24, 2026
H.PIO Market Cap
H.PIO has a market cap or net worth of 85.75 billion as of August 24, 2026. Its market cap has decreased by -16.73% in one year.
Market Cap
85.75B
Enterprise Value
95.53B
Revenue
266.01B
Ranking
n/a
PE Ratio
8.92
Stock Price
2,135.00
ChartMarket Cap Chart
Since May 14, 2021, H.PIO's market cap has decreased from 333.96B to 85.75B, a decrease of -74.32%. That is a compound annual growth rate of -22.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 85.75B | -14.15% |
| Dec 30, 2025 | 99.89B | -1.21% |
| Dec 30, 2024 | 101.11B | -37.21% |
| Dec 28, 2023 | 161.03B | 11.36% |
| Dec 29, 2022 | 144.60B | -46.67% |
| Dec 30, 2021 | 271.16B | -18.81% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DongKoo Bio & Pharma | 99.79B |
| OPTUS Pharmaceutical | 98.82B |
| Sam-A Pharm. | 83.55B |
| KOREA PHARMA | 82.24B |
| Daehan Nupharm | 78.32B |
| Polaris AI Pharma | 68.41B |
| Optipharm.CO.,LTD | 66.97B |
| Hwail Pharmaceutical | 66.84B |